MC2R Antagonists (Pfizer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMC2R Antagonists (Pfizer)
Drug Alias NameMC2R Antagonists (MRC/MRCT/Queen Mary University of London)Melanocortin-2 Receptor Antagonists (MRC/MRCT/Queen Mary University of London)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 2 antagonists
TargetsMelanocortin receptor 2
Therapy Area/IndicationsCushing Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedical Research Council
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifearcPfizer IncQueen Mary University Of London +[4] 
Active IndicationsN/A
Inactive IndicationsCushing Syndrome

Other Information

ATC CodeN/A
Related LinksN/A